# ZORA Ventures

> ZORA Ventures is a VC fund in Tel Aviv backing Biotechnology and Health Care. See 16 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Tel Aviv, Israel
- Total investments: 16
- Last investment: May 2024
- Lead investor: 6%
- Last fund: Jul 2019
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/vanessabartram/
- Website: http://www.zora.vc

ZORA Ventures is a VC fund in Tel Aviv focused on Biotechnology and Health Care. ZORA Ventures backs Israel's leading scientists and founders designing deeptech B2B solutions to the world's most acute climate challenges. Our teams develop climate solutions innovations to be deployed by the world's largest companies across massive markets in order to ignite rapid change at unprecedented scale. Our goal? Back aportfolio of best-in-class companies who will collectively offset or remove a cumulative gigaton of CO2e by 2040.

## Contacts

5 contacts available for ZORA Ventures. Shizune tracks 1 team members at ZORA Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/zora-ventures?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1M–$8.6M |
| Series A | $4M–$8.1M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 5 | 31% |
| Health Care | 3 | 19% |
| Food and Beverage | 3 | 19% |
| Internet | 2 | 13% |
| Software | 2 | 13% |

33 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 11 | 69% |
| Series A | 3 | 19% |
| Convertible Note | 1 | 6% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 10 | 63% |
| United States | 2 | 13% |
| United Kingdom | 1 | 6% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Vanessa Bartram | Managing Partner | 0 | https://shizune.co/investors/profile/vanessa-bartram |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Newmoo | Newmoo makes plant-based cheeses and dairy alternatives. | $7M | Seed | May 28, 2024 |  |
| WeedOut | WeedOut is a biotechnology company focusing on providing weed control solutions. The company’s goal is to reduce the need for toxic herbicides and higher herbicide doses. | $8.1M | Series A | Feb 20, 2024 |  |
| Earth Force Technologies | Earth Force is a Vegetation Management System platform. | $8.6M | Seed | Nov 29, 2022 |  |
| Forsea Foods | Forsea is a cultivated meat company with proprietary, breakthrough technology to produce fish and seafood in a very similar way to nature. | $5.2M | Seed | Oct 26, 2022 |  |
| Rewind | Operator of a facility intended to capture carbon dioxide in agricultural waste on the bottom of the black sea. The company aim's to leave a world of abundance and climate stability for future generations by storing organic carbon in anoxic water where plants decompose extremely slowly to restore the earth's carbon balance, enablingclients effective store carbon for a much longer period. |  | Seed | Mar 10, 2022 |  |
| BiotaX | Biotax is a leading provider of cutting-edge technologies and services, offering biological and genomic informatics solutions for pharma companies, hospitals, and medical centers. Founded by a group of leading researchers who's mission is to help patients by creating new diagnostics and treatments protocols. |  | Seed | Feb 08, 2021 |  |
| EyeControl | EyeControl is a pioneer of medical technology, specializing in innovative communication solutions that address unmet healthcare needs. We implement disruptive AI-technologies that connect people and bridge information barriers, facilitating better medical care and decision-making. Our eye-tracking wearable and smart platforms empowercomprehensive, round-the-clock, bi-directional connectivity between patients with communication difficulties, their families, and medical teams. Using adaptive, ML-based pattern recognition, eye gestures are analyzed and converted to real-time communication and actionable clinical data for patients with various levels of cognition. Established in 2016 by individuals, who share unique personal connections to Locked-in patients, EyeControl is a privately held, rapidly growing startup. Recognized as spearheads of cutting-edge medical innovation, the company is supported by the European Innovation Council, Israel Innovation Authority, investors and advisors representing various sectors.The EyeControl device is FDA listed, CE marked, ISO certified, AMAR registered, and HIPAA compliant; it is federally reimbursed in Israel, the UK, and the US. Clinical trials validating its efficacy in detecting and mitigating Delirium are underway in Israel and the US. |  | Series A | Aug 12, 2020 |  |
| Amai Proteins | Amai Proteins ('Amai' is 'sweet' in Japanese) is transforming the food and beverage industry by presenting healthy and tasty protein ingredients for everyday use. The Designer Protein Company first focus is Sweet Designer Proteins as sugar substitutes. Amai is taking sweet proteins found in the equatorial belt and is applyingAgile Integrative Computational Protein Design (AI-CPD) and fermentation to make the proteins fit for the mass food market. | $1M | Seed | Apr 30, 2020 |  |
| Amai Proteins | Amai Proteins ('Amai' is 'sweet' in Japanese) is transforming the food and beverage industry by presenting healthy and tasty protein ingredients for everyday use. The Designer Protein Company first focus is Sweet Designer Proteins as sugar substitutes. Amai is taking sweet proteins found in the equatorial belt and is applyingAgile Integrative Computational Protein Design (AI-CPD) and fermentation to make the proteins fit for the mass food market. | $6M | Series A | Apr 06, 2020 |  |
| WeedOut | WeedOut is a biotechnology company focusing on providing weed control solutions. The company’s goal is to reduce the need for toxic herbicides and higher herbicide doses. | $4M | Series A | Feb 20, 2020 |  |

10 of 16 investments shown.

## Co-investors
- [Alley Robotics Ventures](https://shizune.co/investors/profile/alley-robotics-ventures) — VC Fund, 1 deal together
- [Aston Partners](https://shizune.co/investors/profile/aston-partners) — VC Fund, 1 deal together
- [Benslie Investment Group](https://shizune.co/investors/profile/benslie-international-ltd) — VC Fund, 1 deal together
- [Bold Capital Partners](https://shizune.co/investors/profile/bold-capital) — VC Fund, 1 deal together
- [Bunge Ventures](https://shizune.co/investors/profile/bunge-ventures) — VC Fund, 1 deal together
- [Clocktower Technology Ventures](https://shizune.co/investors/profile/clocktower-technology-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [F6 Ventures](https://shizune.co/investors/profile/flat6labs) — VC Fund
- [Oqal](https://shizune.co/investors/profile/oqal) — VC Fund
- [Alesta Yatırım](https://shizune.co/investors/profile/alesta-girisim) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in Middle East](https://shizune.co/investors/biotechnology-investors-middle-east)
- [Biotechnology VC Funds in Middle East](https://shizune.co/investors/biotechnology-vc-funds-middle-east)
- [Biotech Investors in Middle East](https://shizune.co/investors/biotech-investors-middle-east)
- [Biotech VC Funds in Middle East](https://shizune.co/investors/biotech-vc-funds-middle-east)
- [Biotech Investors in Israel](https://shizune.co/investors/biotech-investors-israel)
- [Biotech VC Funds in Israel](https://shizune.co/investors/biotech-vc-funds-israel)

## FAQ

### What does ZORA Ventures invest in?

ZORA Ventures invests primarily in Biotechnology, Health Care and Food and Beverage startups, most often at Seed and Series A stage. Most of the 16 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is ZORA Ventures's check size?

ZORA Ventures typically joins rounds of $1M–$8.6M at Seed and $4M–$8.1M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds ZORA Ventures participates in.

### How do I contact ZORA Ventures?

Public channels for ZORA Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at ZORA Ventures?

The team at ZORA Ventures includes Vanessa Bartram (Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co